Furthermore, studies have shown that the miRNA-145/143 cluster targets the 3′-UTR of the ERBB2 gene, which has been linked with breast cancer multidrug resistance in a subtype dependent manner [181]. The gene discussed is ERBB2; the disease is breast carcinoma.